Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 Banned: Key Facts on the Latest FDA Decision FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA to Convene Pharmacy Compounding Advisory Committee in July 503 A Compounding Pharmacies TikTok